Cancer Treatment Center
The King's Daughters' Health cancer care program is accredited by the American College of Surgeons Commission on Cancer—ensuring that local patients receive the highest level of cancer services. In place for nearly 20 years, King’s Daughters’ Health began its oncology (cancer) program in 1998.
During our most recent accreditation process (2015), we received accreditation with commendation—including the Gold Status achievement award, awarded to only about 15 percent of cancer centers across the nation. We're very proud of our Outstanding Achievement Award.
It’s common for cancer patients to have a lot of questions. That's why KDH provides a pair of patient navigators: Candace Sigmon, Certified Oncology Nurse (OCN), and Julie Wehner, Office Coordinator. They provide support, counseling and guidance during the cancer care process. Julie and Candace help patients and families access resources as needed. Call the Cancer Treatment Center at 812.801.0603 and ask for the patient navigator.
Norton Healthcare affiliation
To build upon its already strong cancer care program, the KDH Cancer Treatment Center is affiliated with Norton Cancer Institute to provide physician care and program support for cancer treatment in Madison, Indiana. Shawn Glisson, MD, FACP, and George Goldsmith, MD, (oncology/hematology), care for patients at the KDH Cancer Treatment Center in Madison.
Additionally, the Norton Cancer Center affiliation allows KDH to provide local cancer patients access to a variety of research activities and protocols. Through this partnership, KDH will continue to provide exceptional cancer care services in Madison—allowing local cancer patients the option to obtain the best care possible without the need for travel, reducing stress on both the patient and the patient's family.
Note: The affiliation with Norton Cancer Institute is for cancer (oncology) services only. As an organization, King's Daughters' Health remains fully independent.
American Cancer Society member
The KDH Cancer Treatment Center is a five-star member of the American Cancer Society, which provides additional information and support to cancer patients and their families. We also partner with the American Cancer Society to promote cancer awareness and support. Events include the local Relay For Life and Cancer Survivors Day programs.
Public reporting of outcomes
Vaccinations were one of the 10 most important health improvements of the 20th Century. A hundred years ago, it was common for parents to expect to lose one or more children to a childhood illness. Today, losing a child to a preventable illness in the United States has become a rare occurrence. Thus, despite our culture’s waning appreciation of vaccines, pediatricians continue to champion the life-saving benefits provided by vaccination programs.
In 2006, Gardasil was developed and introduced to protect us against certain strains of human papillomavirus or HPV. The HPV virus is known to cause cervical cancer in women, and it can increase the risk of other HPV-related cancers in both men and women. Despite this information, vaccination rates for HPV continue to be low across the U.S., with Indiana one of the lowest performing states (under 50% vaccination rate).
Participating in a state-wide initiative to increase HPV vaccination rates, one of our goals is to improve the appropriate, local delivery of the HPV vaccine. The first step in the process was to identify barriers, which included proper identification, access for those in need, concerns for safety, and perceived risk versus benefit. Since this vaccine must be given to adolescents aged 9-26, and since it is recommended between the ages of 11-12, the pediatrics office at King’s Daughters’ Health (KDH) began a performance improvement project in January, 2017.
With new processes now in place, we feel we can better identify patients who have not received adequate HPV vaccination. We are also are better equipped to educate these patients about the risk vs. benefit of the vaccine. With improved awareness and education, we believe vaccination rates will improve. Ultimately, we feel confident that we can reach local adolescents with at least the first, most important HPV vaccine dose more often than the state average. Further, we will continue working to improve completion of the appropriate two-or-three-dose series so that we have the best chance to stop HPV-associated cancers throughout the lives of these patients.
Based on recent data, use of the HPV vaccine has already decreased prevalence of HPV by one-third (1/3) during its first decade of use. In that same time period, particularly dangerous strains of HPV were reduced in adolescents by two-thirds (2/3). We want to continue building on these results.
Community Health Needs Assessment
In October 2016, King's Daughters' Healthcompleted its most recent Community Health Needs Assessment (CHNA). Needs Assessments are completed every three years.
The top health issues identified in the 2016 CHNAwere similar to those from the 2013 needs assessment: substance/tobacco use, obesity and mental health. Access to care was again identified as a barrier. King's Daughters' Health uses the Community Health Needs Assessment to help develop strategies and partnerships in the community.
Learn more ...